Adipogen/SUMO Conjugation Negative Control Peptide Substrate (Biotin)/AG-CP3-0020-C020/20 µg
More Information Product Details
Synonyms Small Ubiquitin-like Modifiers Negative Control Peptide Substrate |
Product Type Chemical |
Properties
MW 1.53kDa |
Purity Chemicals ≥90% (HPLC) |
Appearance White lyophilized powder. |
Solubility Soluble in water or other aqueous buffers (5mg/ml). |
Formulation Lyophilized from a 0.2 μm filtered solution in Acetic Acid. |
Crossreactivity Multi-species |
Declaration Manufactured by Boston Biochem |
Other Product Data Use: Negative control and contains a scrambled version of the consensus motif sequence. It will not be conjugated to SUMO-1, SUMO-2 or SUMO-3 proteins in the presence of the E1 activating (SAE1/SAE2) and UbcH9 conjugating enzymes. The biotin group allows for sensitive and convenient detection using avidin-linked reagents. Add stock to in vitro or in vivo assays at desired concentration. Recommended concentration range is 50-100μM depending on conditions. |
Shipping and Handling
Shipping AMBIENT |
Short Term Storage +4°C |
Long Term Storage -20°C |
Handling Advice Aliquot to avoid freeze/thaw cycles. |
Use/Stability Stable for at least 1 year after receipt when stored at -20°C. |
Documents
MSDS Download PDF |
Product Specification Sheet
Datasheet Download PDF |
Small ubiquitin-like Modifiers (SUMOs) are a family of small, related proteins that can be enzymatically attached to a target protein by a post-translational modification process termed SUMOylation. There are four known SUMOs (SUMO1-4). All SUMO proteins share a conserved ubiquitin domain and a C-terminal diglycine cleavage/attachment site. Following cleavage of a C-terminal prosegment, the C-terminal glycine residue of SUMO is enzymatically attached to a lysine residue on a target protein. In humans, SUMO is conjugated to a variety of molecules in the presence of the SAE1/UBA2 SUMO-activating (E1) enzyme and the UBE2I/Ubc9 SUMO-conjugating (E2) enzyme. In yeast, the SUMO-activating (E1) enzyme is Aos1/Uba2p. SUMOylation can occur without the requirement of a specific SUMO ligase (E3), where SUMO is transferred directly from UBE2I/Ubc9 to specific substrates. Unlike SUMO1, which is usually conjugated to proteins as a monomer, SUMO2 and SUMO3 are known to form high molecular weight polymers on proteins. SUMO precursor processing and deconjugation are catalyzed by a family of cysteine proteases known as SUMO-specific proteases (SENPs) and DeSUMOylating Isopeptidase 1.